Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received December 16, 2015
- Revision received January 21, 2016
- Accepted January 28, 2016
- Published online March 14, 2016.
Copyright & Usage
Copyright© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Author Information
- MARTIN SVATON1⇑,
- ONDREJ FIALA2,3,
- MILOS PESEK1,
- ZBYNEK BORTLICEK4,
- MAREK MINARIK5,
- LUCIE BENESOVA5 and
- ONDREJ TOPOLCAN6
- 1Department of Pneumology, University Hospital Pilsen, Charles University in Prague, Prague, Czech Republic
- 2Department of Oncology and Radiotherapy, University Hospital Pilsen, Charles University in Prague, Prague, Czech Republic
- 3Biomedical Center, Faculty of Medicine in Pilsen, Charles University in Prague, Prague, Czech Republic
- 4Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic
- 5Centre for Applied Genomics of Solid Tumours, Genomac Research Institute, Prague, Czech Republic
- 6Department of Nuclear Medicine, Faculty of Medicine in Pilsen, Charles University in Prague, Prague, Czech Republic
- Correspondence to: Martin Svaton, MD, Department of Pneumology, Faculty of Medicine in Pilsen, Charles University in Prague, University Hospital Pilsen, Edvarda Benese 13, CZ-305 99 Pilsen, Czech Republic. Tel: +420 728129259, e-mail: svatonm{at}gmail.com
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- Genotyping KRAS and EGFR Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment
- The likelihood of heterogeneity or additional mutation in KRAS or associated oncogenes to compromise targeting of oncogenic KRAS G12C
- EGFR-Mutant Non-Small Cell Lung Cancer in the Era of Precision Medicine: Importance of Germline EGFR T790M Testing
- Epidermal growth factor receptor mutations should be considered as a prognostic factor for survival of patients with pathological fractures or painful bone metastases from non-small cell lung cancer